

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.37945466 |
| 2 | GDP-mannose metabolic process (GO:0019673) | 5.10048245 |
| 3 | glycine metabolic process (GO:0006544) | 4.84284679 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.83052288 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.83052288 |
| 6 | lysine catabolic process (GO:0006554) | 4.67181509 |
| 7 | lysine metabolic process (GO:0006553) | 4.67181509 |
| 8 | regulation of mitochondrial translation (GO:0070129) | 4.61317559 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 4.48601041 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.48601041 |
| 11 | glyoxylate metabolic process (GO:0046487) | 4.32272524 |
| 12 | protein maturation by protein folding (GO:0022417) | 4.31343588 |
| 13 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.27875058 |
| 14 | serine family amino acid biosynthetic process (GO:0009070) | 4.24985507 |
| 15 | cysteine metabolic process (GO:0006534) | 4.17788115 |
| 16 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.14329710 |
| 17 | serine family amino acid catabolic process (GO:0009071) | 4.13969115 |
| 18 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.12081774 |
| 19 | serine family amino acid metabolic process (GO:0009069) | 4.11910055 |
| 20 | kynurenine metabolic process (GO:0070189) | 3.96439034 |
| 21 | ribosomal small subunit biogenesis (GO:0042274) | 3.93529922 |
| 22 | aromatic amino acid family catabolic process (GO:0009074) | 3.91923676 |
| 23 | DNA deamination (GO:0045006) | 3.88427384 |
| 24 | metallo-sulfur cluster assembly (GO:0031163) | 3.86669834 |
| 25 | iron-sulfur cluster assembly (GO:0016226) | 3.86669834 |
| 26 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.82141495 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 3.74895139 |
| 28 | NADH metabolic process (GO:0006734) | 3.72899553 |
| 29 | L-serine metabolic process (GO:0006563) | 3.70376448 |
| 30 | folic acid metabolic process (GO:0046655) | 3.67992130 |
| 31 | aspartate family amino acid catabolic process (GO:0009068) | 3.65742864 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.63792596 |
| 33 | proteasome assembly (GO:0043248) | 3.62491805 |
| 34 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.60386932 |
| 35 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.58714659 |
| 36 | histone arginine methylation (GO:0034969) | 3.55357218 |
| 37 | negative regulation of ligase activity (GO:0051352) | 3.54950972 |
| 38 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.54950972 |
| 39 | homocysteine metabolic process (GO:0050667) | 3.52521956 |
| 40 | tryptophan catabolic process (GO:0006569) | 3.51893909 |
| 41 | indole-containing compound catabolic process (GO:0042436) | 3.51893909 |
| 42 | indolalkylamine catabolic process (GO:0046218) | 3.51893909 |
| 43 | urea cycle (GO:0000050) | 3.51837188 |
| 44 | urea metabolic process (GO:0019627) | 3.51837188 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 3.50866128 |
| 46 | 2-oxoglutarate metabolic process (GO:0006103) | 3.50043062 |
| 47 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.49893589 |
| 48 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.46608824 |
| 49 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.45599426 |
| 50 | tetrahydrofolate metabolic process (GO:0046653) | 3.45201049 |
| 51 | protein targeting to mitochondrion (GO:0006626) | 3.44057635 |
| 52 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.43216462 |
| 53 | alpha-linolenic acid metabolic process (GO:0036109) | 3.43211239 |
| 54 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.42542697 |
| 55 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.42173695 |
| 56 | chaperone-mediated protein transport (GO:0072321) | 3.40659087 |
| 57 | DNA strand elongation (GO:0022616) | 3.39261446 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 3.38342661 |
| 59 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.37570391 |
| 60 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.37570391 |
| 61 | negative regulation of fibrinolysis (GO:0051918) | 3.37558279 |
| 62 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.37044322 |
| 63 | peptidyl-arginine N-methylation (GO:0035246) | 3.36744999 |
| 64 | peptidyl-arginine methylation (GO:0018216) | 3.36744999 |
| 65 | one-carbon metabolic process (GO:0006730) | 3.36239814 |
| 66 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.34452673 |
| 67 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.34452673 |
| 68 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.34452673 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 3.34414947 |
| 70 | bile acid biosynthetic process (GO:0006699) | 3.34084509 |
| 71 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.34034209 |
| 72 | tryptophan metabolic process (GO:0006568) | 3.33802779 |
| 73 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.33689687 |
| 74 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.33689687 |
| 75 | pseudouridine synthesis (GO:0001522) | 3.33621005 |
| 76 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.33455200 |
| 77 | ATP synthesis coupled proton transport (GO:0015986) | 3.33455200 |
| 78 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.30283081 |
| 79 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.29965525 |
| 80 | nitrogen cycle metabolic process (GO:0071941) | 3.28121025 |
| 81 | establishment of integrated proviral latency (GO:0075713) | 3.27693768 |
| 82 | ethanol oxidation (GO:0006069) | 3.24434932 |
| 83 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.24115917 |
| 84 | transcription from mitochondrial promoter (GO:0006390) | 3.23576305 |
| 85 | oxidative phosphorylation (GO:0006119) | 3.21434362 |
| 86 | nucleobase biosynthetic process (GO:0046112) | 3.19901084 |
| 87 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.19227856 |
| 88 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.17676037 |
| 89 | oxaloacetate metabolic process (GO:0006107) | 3.16860841 |
| 90 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.16209153 |
| 91 | tricarboxylic acid cycle (GO:0006099) | 3.16139573 |
| 92 | cellular amino acid catabolic process (GO:0009063) | 3.15297754 |
| 93 | rRNA modification (GO:0000154) | 3.14026231 |
| 94 | regulation of protein activation cascade (GO:2000257) | 3.12349076 |
| 95 | establishment of viral latency (GO:0019043) | 3.11744267 |
| 96 | valine metabolic process (GO:0006573) | 3.11505165 |
| 97 | establishment of protein localization to mitochondrion (GO:0072655) | 3.11133513 |
| 98 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.09718596 |
| 99 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.08693378 |
| 100 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.08693378 |
| 101 | purine nucleobase biosynthetic process (GO:0009113) | 3.08576228 |
| 102 | rRNA transcription (GO:0009303) | 3.07740330 |
| 103 | pentose metabolic process (GO:0019321) | 3.07389437 |
| 104 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.07201029 |
| 105 | positive regulation of ligase activity (GO:0051351) | 3.06346596 |
| 106 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.06334192 |
| 107 | deoxyribonucleotide catabolic process (GO:0009264) | 3.06259352 |
| 108 | regulation of translational termination (GO:0006449) | 3.04981617 |
| 109 | respiratory electron transport chain (GO:0022904) | 3.04552441 |
| 110 | UTP biosynthetic process (GO:0006228) | 3.04402490 |
| 111 | regulation of translational fidelity (GO:0006450) | 3.04195521 |
| 112 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.03860694 |
| 113 | cellular modified amino acid catabolic process (GO:0042219) | 3.03428602 |
| 114 | ribosome biogenesis (GO:0042254) | 3.01754207 |
| 115 | formation of translation preinitiation complex (GO:0001731) | 3.01270936 |
| 116 | aromatic amino acid family metabolic process (GO:0009072) | 3.01021154 |
| 117 | high-density lipoprotein particle remodeling (GO:0034375) | 3.00080453 |
| 118 | folic acid-containing compound metabolic process (GO:0006760) | 2.99943585 |
| 119 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.99530349 |
| 120 | regulation of triglyceride catabolic process (GO:0010896) | 2.99371431 |
| 121 | proline biosynthetic process (GO:0006561) | 2.99020768 |
| 122 | negative regulation of B cell apoptotic process (GO:0002903) | 2.97701251 |
| 123 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.97259268 |
| 124 | termination of RNA polymerase III transcription (GO:0006386) | 2.97259268 |
| 125 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.97145576 |
| 126 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.97145576 |
| 127 | fatty acid beta-oxidation (GO:0006635) | 2.96494936 |
| 128 | electron transport chain (GO:0022900) | 2.96475987 |
| 129 | acetyl-CoA metabolic process (GO:0006084) | 2.95962256 |
| 130 | aspartate family amino acid metabolic process (GO:0009066) | 2.95832145 |
| 131 | deoxyribose phosphate catabolic process (GO:0046386) | 2.95377688 |
| 132 | regulation of fibrinolysis (GO:0051917) | 2.95100323 |
| 133 | branched-chain amino acid catabolic process (GO:0009083) | 2.94325811 |
| 134 | tricarboxylic acid metabolic process (GO:0072350) | 2.94038794 |
| 135 | regulation of complement activation (GO:0030449) | 2.93744844 |
| 136 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.92978422 |
| 137 | carnitine metabolic process (GO:0009437) | 2.92519392 |
| 138 | protein localization to mitochondrion (GO:0070585) | 2.90370013 |
| 139 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.90198322 |
| 140 | negative regulation of sterol transport (GO:0032372) | 2.89994361 |
| 141 | negative regulation of cholesterol transport (GO:0032375) | 2.89994361 |
| 142 | monosaccharide biosynthetic process (GO:0046364) | 2.89765869 |
| 143 | nuclear envelope reassembly (GO:0031468) | 2.89581882 |
| 144 | mitotic nuclear envelope reassembly (GO:0007084) | 2.89581882 |
| 145 | maturation of SSU-rRNA (GO:0030490) | 2.89074732 |
| 146 | proline metabolic process (GO:0006560) | 2.88100988 |
| 147 | COPI coating of Golgi vesicle (GO:0048205) | 2.87857601 |
| 148 | Golgi transport vesicle coating (GO:0048200) | 2.87857601 |
| 149 | sulfur amino acid biosynthetic process (GO:0000097) | 2.86045640 |
| 150 | complement activation, alternative pathway (GO:0006957) | 2.85718255 |
| 151 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.85520234 |
| 152 | pentose-phosphate shunt (GO:0006098) | 2.85378803 |
| 153 | viral mRNA export from host cell nucleus (GO:0046784) | 2.83835134 |
| 154 | GTP biosynthetic process (GO:0006183) | 2.83304629 |
| 155 | ribosomal small subunit assembly (GO:0000028) | 2.82705420 |
| 156 | peptidyl-histidine modification (GO:0018202) | 2.82342224 |
| 157 | viral transcription (GO:0019083) | 2.82161621 |
| 158 | cellular ketone body metabolic process (GO:0046950) | 2.81650902 |
| 159 | nucleoside salvage (GO:0043174) | 2.80753966 |
| 160 | positive regulation of cell cycle arrest (GO:0071158) | 2.80049326 |
| 161 | spliceosomal snRNP assembly (GO:0000387) | 2.79877416 |
| 162 | rRNA processing (GO:0006364) | 2.79641953 |
| 163 | gluconeogenesis (GO:0006094) | 2.79493069 |
| 164 | organic acid catabolic process (GO:0016054) | 2.79436251 |
| 165 | carboxylic acid catabolic process (GO:0046395) | 2.79436251 |
| 166 | pteridine-containing compound metabolic process (GO:0042558) | 2.79237097 |
| 167 | hexose biosynthetic process (GO:0019319) | 2.78779058 |
| 168 | bile acid metabolic process (GO:0008206) | 2.78579596 |
| 169 | translational elongation (GO:0006414) | 2.77813486 |
| 170 | short-chain fatty acid metabolic process (GO:0046459) | 2.77654160 |
| 171 | branched-chain amino acid metabolic process (GO:0009081) | 2.77513411 |
| 172 | regulation of ligase activity (GO:0051340) | 2.77387523 |
| 173 | aldehyde catabolic process (GO:0046185) | 2.77329863 |
| 174 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.75542513 |
| 175 | translational termination (GO:0006415) | 2.75338767 |
| 176 | fatty acid oxidation (GO:0019395) | 2.75131642 |
| 177 | regulation of cholesterol homeostasis (GO:2000188) | 2.74754889 |
| 178 | chaperone-mediated protein complex assembly (GO:0051131) | 2.74532449 |
| 179 | IMP biosynthetic process (GO:0006188) | 2.73232376 |
| 180 | triglyceride homeostasis (GO:0070328) | 2.73214642 |
| 181 | acylglycerol homeostasis (GO:0055090) | 2.73214642 |
| 182 | DNA unwinding involved in DNA replication (GO:0006268) | 2.72406561 |
| 183 | protein carboxylation (GO:0018214) | 2.71082209 |
| 184 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.71082209 |
| 185 | dicarboxylic acid metabolic process (GO:0043648) | 2.70031404 |
| 186 | sulfur amino acid metabolic process (GO:0000096) | 2.69681609 |
| 187 | glutamate metabolic process (GO:0006536) | 2.68117900 |
| 188 | 4-hydroxyproline metabolic process (GO:0019471) | 2.67455118 |
| 189 | lipid oxidation (GO:0034440) | 2.67019766 |
| 190 | fatty acid catabolic process (GO:0009062) | 2.65054000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.95410812 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.17393769 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.95053447 |
| 4 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.63026136 |
| 5 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.59086459 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.21331653 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.13003849 |
| 8 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.53570513 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.45012873 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.35608514 |
| 11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.35501590 |
| 12 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.25863320 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.23917333 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.18636109 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.16502617 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.10361901 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.05968540 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.02120473 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.99677968 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.96689099 |
| 21 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.90418103 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.89661598 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.88335420 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.86391620 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.86162200 |
| 26 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85230865 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85071332 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.82455314 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.74441968 |
| 30 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.70536075 |
| 31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.67388069 |
| 32 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.66998302 |
| 33 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66611593 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.64399888 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60865789 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.60706359 |
| 37 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.59736279 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.53324974 |
| 39 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.52819975 |
| 40 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.48129075 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.47703502 |
| 42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.41814042 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.41091898 |
| 44 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.40629197 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.40492218 |
| 46 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39540831 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.38962528 |
| 48 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36382836 |
| 49 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.36143233 |
| 50 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.36085131 |
| 51 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.36036876 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.35353556 |
| 53 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34572635 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34448443 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34132275 |
| 56 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.33403370 |
| 57 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33259677 |
| 58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.31939264 |
| 59 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29331767 |
| 60 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.28841810 |
| 61 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.27455092 |
| 62 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24620008 |
| 63 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.24413041 |
| 64 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.22582910 |
| 65 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.21995502 |
| 66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.21760528 |
| 67 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.21534016 |
| 68 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.20047760 |
| 69 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19439617 |
| 70 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18979226 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18262723 |
| 72 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.18120152 |
| 73 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.17778029 |
| 74 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.16335531 |
| 75 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16001273 |
| 76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15898039 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14693196 |
| 78 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14053642 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13613247 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13586325 |
| 81 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.13573596 |
| 82 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.12739126 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12583530 |
| 84 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12121964 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11970615 |
| 86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11801798 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.11767870 |
| 88 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09694596 |
| 89 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09616656 |
| 90 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09126798 |
| 91 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08047121 |
| 92 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07500748 |
| 93 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.06826411 |
| 94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06540777 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06536880 |
| 96 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.06385041 |
| 97 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.06331526 |
| 98 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06223519 |
| 99 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.05817246 |
| 100 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05759967 |
| 101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04921818 |
| 102 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.04303840 |
| 103 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03391928 |
| 104 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03102095 |
| 105 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02303243 |
| 106 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.02134511 |
| 107 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.01939886 |
| 108 | ATF3_27146783_Chip-Seq_COLON_Human | 1.01591928 |
| 109 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00729538 |
| 110 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00487394 |
| 111 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96114815 |
| 112 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.94993606 |
| 113 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94268979 |
| 114 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.93491454 |
| 115 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93486219 |
| 116 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.91925407 |
| 117 | P68_20966046_ChIP-Seq_HELA_Human | 0.90214791 |
| 118 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89976149 |
| 119 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88634699 |
| 120 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.88393441 |
| 121 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85863989 |
| 122 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.84369103 |
| 123 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.84143763 |
| 124 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83983073 |
| 125 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.83389338 |
| 126 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.83115145 |
| 127 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.82217088 |
| 128 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81959756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.83733260 |
| 2 | MP0005360_urolithiasis | 5.26623809 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.92519146 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.44459446 |
| 5 | MP0005365_abnormal_bile_salt | 4.11904938 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.09640554 |
| 7 | MP0009840_abnormal_foam_cell | 2.99987128 |
| 8 | MP0005083_abnormal_biliary_tract | 2.73864803 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.69439917 |
| 10 | MP0008260_abnormal_autophagy | 2.50603653 |
| 11 | MP0005332_abnormal_amino_acid | 2.43842806 |
| 12 | MP0003252_abnormal_bile_duct | 2.37032762 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.36097649 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.30151939 |
| 15 | MP0003693_abnormal_embryo_hatching | 2.25985548 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.09771298 |
| 17 | MP0006036_abnormal_mitochondrial_physio | 2.04822784 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.90113358 |
| 19 | MP0003186_abnormal_redox_activity | 1.89233002 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.88430507 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.78913914 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.78646332 |
| 23 | MP0000609_abnormal_liver_physiology | 1.76228593 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.70200385 |
| 25 | MP0005670_abnormal_white_adipose | 1.68417329 |
| 26 | MP0003646_muscle_fatigue | 1.67810091 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.65867328 |
| 28 | MP0000678_abnormal_parathyroid_gland | 1.65217642 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.62556876 |
| 30 | MP0003111_abnormal_nucleus_morphology | 1.62401690 |
| 31 | MP0001661_extended_life_span | 1.58643784 |
| 32 | MP0003195_calcinosis | 1.58437847 |
| 33 | MP0001764_abnormal_homeostasis | 1.55661710 |
| 34 | MP0001873_stomach_inflammation | 1.46474557 |
| 35 | MP0003077_abnormal_cell_cycle | 1.45992196 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.45211997 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.43966991 |
| 38 | MP0002837_dystrophic_cardiac_calcinosis | 1.43930873 |
| 39 | MP0002796_impaired_skin_barrier | 1.43360913 |
| 40 | MP0004858_abnormal_nervous_system | 1.42462995 |
| 41 | MP0002269_muscular_atrophy | 1.39264001 |
| 42 | MP0010094_abnormal_chromosome_stability | 1.37489423 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.36266559 |
| 44 | MP0000759_abnormal_skeletal_muscle | 1.35216862 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 1.34055520 |
| 46 | MP0005330_cardiomyopathy | 1.32957793 |
| 47 | MP0000372_irregular_coat_pigmentation | 1.31592485 |
| 48 | MP0001730_embryonic_growth_arrest | 1.30674663 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.28808645 |
| 50 | MP0001727_abnormal_embryo_implantation | 1.28216051 |
| 51 | MP0005266_abnormal_metabolism | 1.24903733 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.24506961 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.23694200 |
| 54 | MP0000598_abnormal_liver_morphology | 1.23429819 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.23284198 |
| 56 | MP0000490_abnormal_crypts_of | 1.22699480 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.22042070 |
| 58 | MP0003315_abnormal_perineum_morphology | 1.21485778 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19406246 |
| 60 | MP0004084_abnormal_cardiac_muscle | 1.17427610 |
| 61 | MP0000750_abnormal_muscle_regeneration | 1.12918858 |
| 62 | MP0000003_abnormal_adipose_tissue | 1.11017991 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 1.09598837 |
| 64 | MP0003221_abnormal_cardiomyocyte_apopto | 1.08517763 |
| 65 | MP0005666_abnormal_adipose_tissue | 1.07681747 |
| 66 | MP0009278_abnormal_bone_marrow | 1.05251259 |
| 67 | MP0002249_abnormal_larynx_morphology | 1.05074171 |
| 68 | MP0001849_ear_inflammation | 1.02215508 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.01646433 |
| 70 | MP0002132_abnormal_respiratory_system | 1.01487012 |
| 71 | MP0002163_abnormal_gland_morphology | 1.00534829 |
| 72 | MP0001881_abnormal_mammary_gland | 0.99464757 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 0.96334784 |
| 74 | MP0000358_abnormal_cell_content/ | 0.94393261 |
| 75 | MP0000537_abnormal_urethra_morphology | 0.93518214 |
| 76 | MP0003718_maternal_effect | 0.92683689 |
| 77 | MP0000703_abnormal_thymus_morphology | 0.92602387 |
| 78 | MP0000858_altered_metastatic_potential | 0.92579093 |
| 79 | MP0005380_embryogenesis_phenotype | 0.88591291 |
| 80 | MP0001672_abnormal_embryogenesis/_devel | 0.88591291 |
| 81 | MP0003984_embryonic_growth_retardation | 0.87764803 |
| 82 | MP0010030_abnormal_orbit_morphology | 0.87587478 |
| 83 | MP0002080_prenatal_lethality | 0.87367917 |
| 84 | MP0002254_reproductive_system_inflammat | 0.87254597 |
| 85 | MP0004087_abnormal_muscle_fiber | 0.87174979 |
| 86 | MP0005451_abnormal_body_composition | 0.87044838 |
| 87 | MP0008007_abnormal_cellular_replicative | 0.87036512 |
| 88 | MP0004233_abnormal_muscle_weight | 0.86288579 |
| 89 | MP0002088_abnormal_embryonic_growth/wei | 0.86029208 |
| 90 | MP0000749_muscle_degeneration | 0.85783992 |
| 91 | MP0002396_abnormal_hematopoietic_system | 0.83970579 |
| 92 | MP0001697_abnormal_embryo_size | 0.83304465 |
| 93 | MP0005376_homeostasis/metabolism_phenot | 0.83262732 |
| 94 | MP0008932_abnormal_embryonic_tissue | 0.83215591 |
| 95 | MP0002429_abnormal_blood_cell | 0.83026348 |
| 96 | MP0000350_abnormal_cell_proliferation | 0.82790191 |
| 97 | MP0009697_abnormal_copulation | 0.82281368 |
| 98 | MP0005384_cellular_phenotype | 0.80740731 |
| 99 | MP0000681_abnormal_thyroid_gland | 0.80447036 |
| 100 | MP0001756_abnormal_urination | 0.80410220 |
| 101 | MP0000733_abnormal_muscle_development | 0.80296425 |
| 102 | MP0010630_abnormal_cardiac_muscle | 0.80188015 |
| 103 | MP0002722_abnormal_immune_system | 0.79888969 |
| 104 | MP0001346_abnormal_lacrimal_gland | 0.79613189 |
| 105 | MP0001905_abnormal_dopamine_level | 0.78719678 |
| 106 | MP0005375_adipose_tissue_phenotype | 0.78150382 |
| 107 | MP0009672_abnormal_birth_weight | 0.77931468 |
| 108 | MP0002106_abnormal_muscle_physiology | 0.77373501 |
| 109 | MP0002398_abnormal_bone_marrow | 0.77210713 |
| 110 | MP0008058_abnormal_DNA_repair | 0.76448594 |
| 111 | MP0005165_increased_susceptibility_to | 0.76324026 |
| 112 | MP0005671_abnormal_response_to | 0.75788256 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.75358119 |
| 114 | MP0003868_abnormal_feces_composition | 0.74320522 |
| 115 | MP0001853_heart_inflammation | 0.74076487 |
| 116 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72217052 |
| 117 | MP0003123_paternal_imprinting | 0.72046112 |
| 118 | MP0005220_abnormal_exocrine_pancreas | 0.71565872 |
| 119 | MP0000747_muscle_weakness | 0.71029333 |
| 120 | MP0004215_abnormal_myocardial_fiber | 0.71005796 |
| 121 | MP0008057_abnormal_DNA_replication | 0.70811318 |
| 122 | MP0005023_abnormal_wound_healing | 0.70567181 |
| 123 | MP0004197_abnormal_fetal_growth/weight/ | 0.69635954 |
| 124 | MP0000689_abnormal_spleen_morphology | 0.68283691 |
| 125 | MP0009763_increased_sensitivity_to | 0.68206268 |
| 126 | MP0003075_altered_response_to | 0.68109244 |
| 127 | MP0002086_abnormal_extraembryonic_tissu | 0.67947607 |
| 128 | MP0009053_abnormal_anal_canal | 0.67672803 |
| 129 | MP0009642_abnormal_blood_homeostasis | 0.67646441 |
| 130 | MP0004133_heterotaxia | 0.67005599 |
| 131 | MP0002078_abnormal_glucose_homeostasis | 0.66894527 |
| 132 | MP0002019_abnormal_tumor_incidence | 0.66329659 |
| 133 | MP0004130_abnormal_muscle_cell | 0.65934459 |
| 134 | MP0005647_abnormal_sex_gland | 0.65733650 |
| 135 | MP0004147_increased_porphyrin_level | 0.65382591 |
| 136 | MP0000751_myopathy | 0.64977457 |
| 137 | MP0002970_abnormal_white_adipose | 0.64788262 |
| 138 | MP0008469_abnormal_protein_level | 0.64355006 |
| 139 | MP0002653_abnormal_ependyma_morphology | 0.63516276 |
| 140 | MP0005501_abnormal_skin_physiology | 0.62978618 |
| 141 | MP0008775_abnormal_heart_ventricle | 0.62764007 |
| 142 | MP0004036_abnormal_muscle_relaxation | 0.62014026 |
| 143 | MP0005385_cardiovascular_system_phenoty | 0.61656011 |
| 144 | MP0001544_abnormal_cardiovascular_syste | 0.61656011 |
| 145 | MP0000313_abnormal_cell_death | 0.60891665 |
| 146 | MP0003011_delayed_dark_adaptation | 0.58954153 |
| 147 | MP0003786_premature_aging | 0.58841316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.02096673 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.81717082 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.58003310 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 4.55378792 |
| 5 | Hyperammonemia (HP:0001987) | 4.52501386 |
| 6 | Hyperglycinuria (HP:0003108) | 4.25820421 |
| 7 | Microvesicular hepatic steatosis (HP:0001414) | 4.18513142 |
| 8 | Deep venous thrombosis (HP:0002625) | 4.10363966 |
| 9 | Hyperglycinemia (HP:0002154) | 3.95288594 |
| 10 | Ketosis (HP:0001946) | 3.84681952 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.83586787 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 3.83586787 |
| 13 | Xanthomatosis (HP:0000991) | 3.79134397 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.74220616 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.71249021 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.65955173 |
| 17 | Mitochondrial inheritance (HP:0001427) | 3.54902676 |
| 18 | Dicarboxylic aciduria (HP:0003215) | 3.47686169 |
| 19 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.47686169 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.46918659 |
| 21 | Hypolipoproteinemia (HP:0010981) | 3.35770175 |
| 22 | Acute necrotizing encephalopathy (HP:0006965) | 3.32550305 |
| 23 | Microretrognathia (HP:0000308) | 3.31774058 |
| 24 | Rhabdomyolysis (HP:0003201) | 3.25572028 |
| 25 | Myopathic facies (HP:0002058) | 3.24570326 |
| 26 | Testicular atrophy (HP:0000029) | 3.24497962 |
| 27 | Myoglobinuria (HP:0002913) | 3.22616482 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.22560101 |
| 29 | Ketoacidosis (HP:0001993) | 3.19314898 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.16065070 |
| 31 | Exercise intolerance (HP:0003546) | 3.09416221 |
| 32 | Abnormality of serum amino acid levels (HP:0003112) | 3.04574098 |
| 33 | Type I transferrin isoform profile (HP:0003642) | 3.03313830 |
| 34 | Hepatic necrosis (HP:0002605) | 3.02374413 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.02328402 |
| 36 | Lethargy (HP:0001254) | 3.01157193 |
| 37 | Cerebral edema (HP:0002181) | 2.99332422 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.97979374 |
| 39 | Abnormality of methionine metabolism (HP:0010901) | 2.97376330 |
| 40 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.94317613 |
| 41 | Prolonged partial thromboplastin time (HP:0003645) | 2.92595955 |
| 42 | Multiple enchondromatosis (HP:0005701) | 2.86498007 |
| 43 | Exercise-induced myalgia (HP:0003738) | 2.86139736 |
| 44 | Gout (HP:0001997) | 2.82846914 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.80080217 |
| 46 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.77803746 |
| 47 | Ragged-red muscle fibers (HP:0003200) | 2.74929977 |
| 48 | Hyperlipoproteinemia (HP:0010980) | 2.74224514 |
| 49 | Hypoalphalipoproteinemia (HP:0003233) | 2.73871877 |
| 50 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.73721301 |
| 51 | Abnormal protein glycosylation (HP:0012346) | 2.69672080 |
| 52 | Abnormal glycosylation (HP:0012345) | 2.69672080 |
| 53 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.69672080 |
| 54 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.69672080 |
| 55 | Complement deficiency (HP:0004431) | 2.65384882 |
| 56 | Metabolic acidosis (HP:0001942) | 2.64704382 |
| 57 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.64371563 |
| 58 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.64371563 |
| 59 | Late onset (HP:0003584) | 2.64220055 |
| 60 | Oral leukoplakia (HP:0002745) | 2.62488898 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.60342857 |
| 62 | Nausea (HP:0002018) | 2.58351543 |
| 63 | Increased muscle lipid content (HP:0009058) | 2.57025114 |
| 64 | Increased hepatocellular lipid droplets (HP:0006565) | 2.56335924 |
| 65 | Spastic diplegia (HP:0001264) | 2.53803610 |
| 66 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.53649176 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.51680645 |
| 68 | Hepatocellular necrosis (HP:0001404) | 2.51596799 |
| 69 | Cerebral hypomyelination (HP:0006808) | 2.51340381 |
| 70 | Delayed CNS myelination (HP:0002188) | 2.48508003 |
| 71 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.46557305 |
| 72 | Nemaline bodies (HP:0003798) | 2.43441646 |
| 73 | Distal lower limb muscle weakness (HP:0009053) | 2.43302162 |
| 74 | Increased serum lactate (HP:0002151) | 2.42724190 |
| 75 | Reduced antithrombin III activity (HP:0001976) | 2.41455371 |
| 76 | Lactic acidosis (HP:0003128) | 2.40546853 |
| 77 | Rough bone trabeculation (HP:0100670) | 2.40515976 |
| 78 | Progressive muscle weakness (HP:0003323) | 2.39850614 |
| 79 | Muscle fiber inclusion bodies (HP:0100299) | 2.39163693 |
| 80 | Progressive macrocephaly (HP:0004481) | 2.38827059 |
| 81 | Abnormal number of erythroid precursors (HP:0012131) | 2.37990334 |
| 82 | Trismus (HP:0000211) | 2.36799335 |
| 83 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.35923403 |
| 84 | Abnormality of purine metabolism (HP:0004352) | 2.34495815 |
| 85 | Hypokinesia (HP:0002375) | 2.32632159 |
| 86 | Emotional lability (HP:0000712) | 2.32052121 |
| 87 | Abnormality of the common coagulation pathway (HP:0010990) | 2.31420093 |
| 88 | Abnormality of the intrinsic pathway (HP:0010989) | 2.31300209 |
| 89 | Acute encephalopathy (HP:0006846) | 2.29916440 |
| 90 | Fat malabsorption (HP:0002630) | 2.28437545 |
| 91 | Cholelithiasis (HP:0001081) | 2.27363511 |
| 92 | Broad distal phalanx of finger (HP:0009836) | 2.22377013 |
| 93 | Muscle stiffness (HP:0003552) | 2.21069942 |
| 94 | Vomiting (HP:0002013) | 2.20829684 |
| 95 | Respiratory failure (HP:0002878) | 2.17664183 |
| 96 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.17637888 |
| 97 | Abnormal cartilage morphology (HP:0002763) | 2.17208413 |
| 98 | Seborrheic dermatitis (HP:0001051) | 2.16551358 |
| 99 | Respiratory difficulties (HP:0002880) | 2.16473893 |
| 100 | Cholecystitis (HP:0001082) | 2.16165901 |
| 101 | Abnormal gallbladder physiology (HP:0012438) | 2.16165901 |
| 102 | Epidermoid cyst (HP:0200040) | 2.15502823 |
| 103 | Aplastic anemia (HP:0001915) | 2.14826367 |
| 104 | Neonatal onset (HP:0003623) | 2.14776897 |
| 105 | Progressive external ophthalmoplegia (HP:0000590) | 2.12230991 |
| 106 | Increased purine levels (HP:0004368) | 2.11738789 |
| 107 | Hyperuricemia (HP:0002149) | 2.11738789 |
| 108 | Proximal tubulopathy (HP:0000114) | 2.11333833 |
| 109 | Palpitations (HP:0001962) | 2.11251600 |
| 110 | Progressive microcephaly (HP:0000253) | 2.11136717 |
| 111 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.10711143 |
| 112 | Bulbar palsy (HP:0001283) | 2.09894851 |
| 113 | Hypertensive crisis (HP:0100735) | 2.09597871 |
| 114 | Increased serum pyruvate (HP:0003542) | 2.09391613 |
| 115 | Abnormality of glycolysis (HP:0004366) | 2.09391613 |
| 116 | Abnormality of complement system (HP:0005339) | 2.08982523 |
| 117 | Renal Fanconi syndrome (HP:0001994) | 2.08528398 |
| 118 | Increased CSF lactate (HP:0002490) | 2.07874264 |
| 119 | Abnormality of iron homeostasis (HP:0011031) | 2.07623208 |
| 120 | CNS demyelination (HP:0007305) | 2.07600920 |
| 121 | Opisthotonus (HP:0002179) | 2.06490727 |
| 122 | Increased serum ferritin (HP:0003281) | 2.05747843 |
| 123 | Abnormal gallbladder morphology (HP:0012437) | 2.05249234 |
| 124 | Increased intramyocellular lipid droplets (HP:0012240) | 2.04638244 |
| 125 | Malnutrition (HP:0004395) | 2.03731762 |
| 126 | Hypercholesterolemia (HP:0003124) | 2.02052931 |
| 127 | Lipid accumulation in hepatocytes (HP:0006561) | 2.01370856 |
| 128 | Brushfield spots (HP:0001088) | 1.98181690 |
| 129 | Hepatocellular carcinoma (HP:0001402) | 1.96381492 |
| 130 | Right ventricular cardiomyopathy (HP:0011663) | 1.96001249 |
| 131 | Stridor (HP:0010307) | 1.94685384 |
| 132 | Distal lower limb amyotrophy (HP:0008944) | 1.94411865 |
| 133 | Reticulocytopenia (HP:0001896) | 1.93615089 |
| 134 | Abnormality of reticulocytes (HP:0004312) | 1.93571213 |
| 135 | Reticulocytosis (HP:0001923) | 1.93546533 |
| 136 | Achilles tendon contracture (HP:0001771) | 1.93467283 |
| 137 | Abnormality of urine glucose concentration (HP:0011016) | 1.93359243 |
| 138 | Glycosuria (HP:0003076) | 1.93359243 |
| 139 | Secondary amenorrhea (HP:0000869) | 1.92072595 |
| 140 | Death in infancy (HP:0001522) | 1.92025797 |
| 141 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91106037 |
| 142 | Megaloblastic anemia (HP:0001889) | 1.90124341 |
| 143 | Cerebral palsy (HP:0100021) | 1.90021323 |
| 144 | Methylmalonic aciduria (HP:0012120) | 1.89485717 |
| 145 | Ventricular tachycardia (HP:0004756) | 1.89021310 |
| 146 | Abnormality of the gallbladder (HP:0005264) | 1.88682306 |
| 147 | Abnormality of the Achilles tendon (HP:0005109) | 1.87836701 |
| 148 | Adenoma sebaceum (HP:0009720) | 1.86284943 |
| 149 | Angiofibromas (HP:0010615) | 1.86284943 |
| 150 | Pancytopenia (HP:0001876) | 1.85831970 |
| 151 | Dysphonia (HP:0001618) | 1.82152131 |
| 152 | Premature ovarian failure (HP:0008209) | 1.81620452 |
| 153 | Abnormal trabecular bone morphology (HP:0100671) | 1.81216457 |
| 154 | Spastic paraparesis (HP:0002313) | 1.80713277 |
| 155 | Fasciculations (HP:0002380) | 1.80566698 |
| 156 | Hepatosplenomegaly (HP:0001433) | 1.79471954 |
| 157 | Gliosis (HP:0002171) | 1.75819682 |
| 158 | Abnormality of the umbilical cord (HP:0010881) | 1.75271623 |
| 159 | Generalized amyotrophy (HP:0003700) | 1.73416592 |
| 160 | Neoplasm of head and neck (HP:0012288) | 1.73411406 |
| 161 | Esophageal neoplasm (HP:0100751) | 1.73411406 |
| 162 | Selective tooth agenesis (HP:0001592) | 1.72606448 |
| 163 | Hyperacusis (HP:0010780) | 1.71862299 |
| 164 | Paralysis (HP:0003470) | 1.70159127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.17833009 |
| 2 | VRK2 | 4.22395930 |
| 3 | SMG1 | 3.15879028 |
| 4 | PKN2 | 3.15362744 |
| 5 | ERN1 | 2.99578829 |
| 6 | EIF2AK1 | 2.89381326 |
| 7 | NEK1 | 2.82793677 |
| 8 | TRIB3 | 2.69455272 |
| 9 | BUB1 | 2.64660081 |
| 10 | WEE1 | 2.49955630 |
| 11 | NME2 | 2.46822914 |
| 12 | MAP3K11 | 2.20820574 |
| 13 | FLT3 | 2.07633340 |
| 14 | CDC7 | 2.03918901 |
| 15 | MAP3K10 | 2.00312671 |
| 16 | PDK4 | 1.91697084 |
| 17 | PDK3 | 1.91697084 |
| 18 | IRAK3 | 1.90522806 |
| 19 | MAP2K3 | 1.87808437 |
| 20 | KDR | 1.85152972 |
| 21 | EPHA2 | 1.79960652 |
| 22 | ARAF | 1.78967371 |
| 23 | SCYL2 | 1.74411006 |
| 24 | NEK2 | 1.69989463 |
| 25 | EEF2K | 1.53691912 |
| 26 | FGFR4 | 1.53114278 |
| 27 | RPS6KB2 | 1.48875148 |
| 28 | TESK2 | 1.47806679 |
| 29 | TTK | 1.40675962 |
| 30 | PBK | 1.30016324 |
| 31 | SIK1 | 1.29065216 |
| 32 | TTN | 1.28192328 |
| 33 | LIMK1 | 1.27675934 |
| 34 | DAPK1 | 1.26744819 |
| 35 | LRRK2 | 1.24409471 |
| 36 | MAP3K3 | 1.24187693 |
| 37 | MAPKAPK3 | 1.23339712 |
| 38 | MAP3K8 | 1.21630212 |
| 39 | ACVR1B | 1.21538492 |
| 40 | STK16 | 1.20076530 |
| 41 | CDK4 | 1.20051594 |
| 42 | PIM2 | 1.16450301 |
| 43 | PLK1 | 1.14329728 |
| 44 | TSSK6 | 1.13660195 |
| 45 | TLK1 | 1.13514747 |
| 46 | MAP2K6 | 1.13507757 |
| 47 | CDK7 | 1.09454729 |
| 48 | PAK4 | 1.07113868 |
| 49 | STK38L | 1.06235573 |
| 50 | EIF2AK3 | 1.05671893 |
| 51 | TESK1 | 1.05517756 |
| 52 | MAPK11 | 1.01191790 |
| 53 | AURKA | 1.00221694 |
| 54 | AURKB | 0.99335762 |
| 55 | RPS6KA4 | 0.98908777 |
| 56 | TAOK2 | 0.98547582 |
| 57 | DYRK3 | 0.97468632 |
| 58 | LATS2 | 0.90713205 |
| 59 | PTK6 | 0.88177662 |
| 60 | BRSK2 | 0.84557844 |
| 61 | MAP2K2 | 0.83927653 |
| 62 | STK10 | 0.82898900 |
| 63 | TGFBR1 | 0.82414442 |
| 64 | PASK | 0.81143605 |
| 65 | PHKG1 | 0.80442133 |
| 66 | PHKG2 | 0.80442133 |
| 67 | CDK8 | 0.79437306 |
| 68 | CDK12 | 0.78632447 |
| 69 | ILK | 0.78582684 |
| 70 | LMTK2 | 0.78256088 |
| 71 | ZAK | 0.76845556 |
| 72 | SRPK1 | 0.76428715 |
| 73 | ATR | 0.74745899 |
| 74 | PRPF4B | 0.74516629 |
| 75 | CSNK1G3 | 0.73371047 |
| 76 | PDK2 | 0.72475248 |
| 77 | NME1 | 0.72290835 |
| 78 | SIK3 | 0.71218689 |
| 79 | ABL2 | 0.70300327 |
| 80 | MTOR | 0.66654048 |
| 81 | MST4 | 0.65944073 |
| 82 | PINK1 | 0.63751001 |
| 83 | STK4 | 0.61693433 |
| 84 | DAPK3 | 0.60917690 |
| 85 | CAMK2G | 0.58896901 |
| 86 | MAP3K5 | 0.57473544 |
| 87 | GRK6 | 0.56627251 |
| 88 | BRSK1 | 0.54267491 |
| 89 | MUSK | 0.54170493 |
| 90 | BRAF | 0.53569269 |
| 91 | ICK | 0.53528402 |
| 92 | VRK1 | 0.53294969 |
| 93 | AKT2 | 0.52615743 |
| 94 | PRKCI | 0.51350615 |
| 95 | CSNK2A2 | 0.51031372 |
| 96 | PAK1 | 0.50854284 |
| 97 | TAOK1 | 0.50555121 |
| 98 | CSNK1A1L | 0.50204145 |
| 99 | OBSCN | 0.48511832 |
| 100 | RIPK1 | 0.47396108 |
| 101 | MAP3K1 | 0.46187290 |
| 102 | CHEK1 | 0.44550459 |
| 103 | DYRK1B | 0.44324154 |
| 104 | CCNB1 | 0.43988859 |
| 105 | MST1R | 0.43768754 |
| 106 | CSNK2A1 | 0.43492763 |
| 107 | ZAP70 | 0.43103422 |
| 108 | RPS6KA5 | 0.42043701 |
| 109 | MATK | 0.41904600 |
| 110 | CDK9 | 0.41282205 |
| 111 | MYLK | 0.40441782 |
| 112 | MAP4K1 | 0.39062397 |
| 113 | PIM1 | 0.38147852 |
| 114 | TNK2 | 0.37902265 |
| 115 | CDK11A | 0.37592921 |
| 116 | ALK | 0.36534886 |
| 117 | ERBB4 | 0.35936384 |
| 118 | CDK2 | 0.35823003 |
| 119 | TBK1 | 0.35611283 |
| 120 | TYK2 | 0.34653384 |
| 121 | CHEK2 | 0.33974528 |
| 122 | CDK14 | 0.33163189 |
| 123 | IRAK2 | 0.32579326 |
| 124 | CDK6 | 0.32427442 |
| 125 | CDK15 | 0.31344503 |
| 126 | MAPKAPK2 | 0.31061207 |
| 127 | PRKD3 | 0.29555705 |
| 128 | MAP3K7 | 0.29292912 |
| 129 | PDPK1 | 0.29167232 |
| 130 | NEK9 | 0.27677980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25530598 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.85779148 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.82034256 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.70166296 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.47371731 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38674368 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.36656467 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.27916398 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.26336595 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.25286765 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.18189496 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.18137247 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.13842339 |
| 14 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.11827672 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 2.01025929 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.95964849 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93778290 |
| 18 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.92895893 |
| 19 | Sulfur relay system_Homo sapiens_hsa04122 | 1.90086203 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.89293900 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.82378880 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.82073247 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.80009045 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66051265 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.61818551 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.61675877 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 1.57313193 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.56521877 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56378202 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.56046442 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.52556736 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.52433995 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.48507828 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.47749548 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45948576 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40449144 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.39769874 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.34812233 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.34655127 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33410602 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.32188421 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.30247834 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26709985 |
| 44 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.26625042 |
| 45 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.19637614 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19439250 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.15021058 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.13289012 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13054354 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.12973860 |
| 51 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.11712450 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10149950 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06462298 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06068205 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05646066 |
| 56 | RNA transport_Homo sapiens_hsa03013 | 1.05340593 |
| 57 | RNA polymerase_Homo sapiens_hsa03020 | 1.03110311 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01715568 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99581485 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97517748 |
| 61 | Spliceosome_Homo sapiens_hsa03040 | 0.94493150 |
| 62 | Base excision repair_Homo sapiens_hsa03410 | 0.94087570 |
| 63 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92346059 |
| 64 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.84309992 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83644591 |
| 66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.82431786 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79879589 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79752654 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79220500 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79153607 |
| 71 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.78842749 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.78757806 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77788402 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77711165 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73039022 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.72368137 |
| 77 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.72167270 |
| 78 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.68597228 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.68157852 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67310281 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65054448 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64018028 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63112846 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62392589 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62272360 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60314210 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55747932 |
| 88 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54805241 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52816871 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52598525 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52246727 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49101598 |
| 93 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45702121 |
| 94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45080749 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42167862 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.42112534 |
| 97 | Cell cycle_Homo sapiens_hsa04110 | 0.41857300 |
| 98 | Purine metabolism_Homo sapiens_hsa00230 | 0.40113008 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34932716 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | 0.33967062 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33406393 |
| 102 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.32413512 |
| 103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31892988 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31346675 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30968738 |
| 106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30366533 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.29356014 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29174445 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28875242 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28159229 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.28109546 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26509815 |
| 113 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.26443740 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22546140 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.22413775 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.22380165 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.21320984 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19354838 |
| 119 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.18265117 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.17251480 |
| 121 | Alcoholism_Homo sapiens_hsa05034 | 0.16194768 |
| 122 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14385055 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13636994 |
| 124 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.12679149 |
| 125 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.10493562 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.09946100 |
| 127 | Basal transcription factors_Homo sapiens_hsa03022 | 0.09804337 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.07879518 |
| 129 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.07750930 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.07655469 |

